Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lanolin is a natural yellow fat obtained from the sebaceous glands of sheep and is commonly referred to as wool wax or wool grease. It primarily consists of long-chain waxy esters and sterol esters. Used topically as an emollient and skin protectant in creams and ointments (typically at concentrations of 12-50%), lanolin helps treat or prevent dry skin conditions such as diaper rash, radiation therapy burns, chapped skin from wind or sun exposure, minor burns and sore nipples due to breastfeeding. Its hydrophobic properties help seal in moisture already present in the skin and provide a protective barrier against irritation or infection[1][2][3][4][5][7]. Lanolin's mechanism of action involves acting as a skin protectant and moisturizer by forming an occlusive layer on the skin, reducing water loss and providing a barrier against irritants.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lanolin.